In this Issue:
A phase II trial of autologous haematopoietic stem cell transplantation
Vaccination in fingolimod-treated patients
Epstein-Barr virus genetic variants and MS
Spinal cord atrophy and its association with clinical progression
Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active MS
Relapse rates in MS patients switching from interferon to fingolimod or glatiramer acetate
Peginterferon beta-1a in MS
Mindfulness training for progressive MS
A pilot study of biotin in progressive MS
Test battery to detect MS disease activity
Please login below to download this issue (PDF)